BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38756002)

  • 1. Natural History and Prognostic Model of Untreated Papillary Thyroid Cancer: A SEER Database Analysis.
    Wang D; Yang Y; He Y; Yang H; Yang L
    Cancer Control; 2024; 31():10732748241253956. PubMed ID: 38756002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
    Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
    Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study.
    Wang J; Zhanghuang C; Jin L; Zhang Z; Tan X; Mi T; Liu J; Li M; Wu X; Tian X; He D
    BMC Geriatr; 2022 Sep; 22(1):736. PubMed ID: 36076163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of web
    Zhan G; Cao P; Peng H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer.
    Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T
    Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a nomogram based on stromal score to predict progression-free survival of patients with papillary thyroid carcinoma.
    Tang J; Jiang S; Gao Q; Xi X; Gao L; Zhao R; Lai X; Zhang B; Jiang Y
    Cancer Med; 2021 Aug; 10(16):5488-5498. PubMed ID: 34240816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a nomogram to predict overall survival in patients with redefined anaplastic thyroid carcinoma based on the SEER database.
    Zhang C; Li B; Yang Y
    Int J Clin Oncol; 2024 Jun; 29(6):744-754. PubMed ID: 38584210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program.
    Wang H; Chen X; Zhao J; Kang M; Dong R; Wang K; Qu Y
    Med Sci Monit; 2020 Jun; 26():e921859. PubMed ID: 32570266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
    Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
    Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Age on the Prognosis of Papillary Thyroid Carcinoma.
    Sun Y; Dai W; Liang Y; Xia N
    Arch Iran Med; 2020 Mar; 23(3):169-174. PubMed ID: 32126785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram and risk classification system for predicting cancer-specific survival in tall cell variant of papillary thyroid cancer: a SEER-based study.
    Wang X; Zheng X; Zhu J; Li Z; Wei T
    J Endocrinol Invest; 2023 May; 46(5):893-901. PubMed ID: 36376545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
    Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
    Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
    Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
    Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.
    Oyer SL; Fritsch VA; Lentsch EJ
    Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies and predicting lymph node metastasis in elderly patients with papillary thyroid microcarcinoma.
    Li W; Tang Y; Li J; Han W; Wang D; Wang Y
    Medicine (Baltimore); 2021 May; 100(18):e25811. PubMed ID: 33950985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma: a SEER database analysis.
    Liu C; Chen T; Zeng W; Wang S; Xiong Y; Liu Z; Huang T
    Sci Rep; 2017 Sep; 7(1):11412. PubMed ID: 28900207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Competing Risk Nomogram for Prediction of Prognosis in Patients With Primary Squamous Cell Thyroid Carcinoma.
    Tian Y; He L; Zhang B; Deng L; Wang J
    Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factor analysis and nomogram development and verification for medullary carcinoma of the colon using SEER database.
    Yang L; Yu L; Zhou Q; Liu L; Shen N; Li N
    Sci Rep; 2024 May; 14(1):11426. PubMed ID: 38763982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
    Shi X; Xu L; Ma B; Wang S
    Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomograms for estimating survival in patients with papillary thyroid cancer after surgery.
    Liu G; Liu Q; Sun SR
    Cancer Manag Res; 2019; 11():3535-3544. PubMed ID: 31114382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.